Table 1 Baseline characteristics
|  | Itopride (n = 35) | Metoclopramide (n = 35) | p-value |
|---|---|---|---|
Demographics | |||
Age, years, mean (SD) | 43.94 (12.68) | 42.09 (11.96) | 0.53* |
Height, m, mean (SD) | 1.67 (0.11) | 1.67 (0.09) | 0.89* |
Weight, kg, mean (SD) | 65.94 (13.11) | 67.09 (10.74) | 0.69* |
BMI, kg/m2, mean (SD) | 23.41 (2.34) | 23.91 (2.87) | 0.42* |
Male, n (%) | 14 (40%) | 18 (51.4%) | 0.33** |
Female, n (%) | 21 (60%) | 17 (48.6%) | |
Reasons for ICU admission | |||
Surgical intervention, n (%) | 10 (28.6%) | 9 (25.7%) | Â |
Trauma, n (%) | 10 (28.6%) | 7 (20%) | Â |
CVS disorder, n (%) | 6 (17.1%) | 7 (20%) | Â |
Respiratory disorder, n (%) | 4 (11.4%) | 6 (17.1%) | Â |
Neurological disorder, n (%) | 3 (8.6%) | 3 (8.6%) | Â |
Burn, n (%) | 2 (5.7%) | 3 (8.6%) | Â |
Risk scores, mean (SD) | |||
APACHE II | 22.19 (3.67) | 21.79 (4.04) | 0.66* |
SOFA | 8.60 (1.33) | 8.83 (1.48) | 0.49* |
mNUTRIC | 5.54 (1.22) | 5.46 (0.98) | 0.7* |
Enteral nutritional targets, mean (SD) | |||
Volume prescribed (ml/day) | 1310.66 (67.089) | 1333.03 (63.461) | 0.156* |
Estimated energy requirements (kcal/d) | 1757.14 (185.561) | 1754.29 (137.932) | 0.942* |
Estimated protein requirements (g/d) | 90.14 (8.357) | 93 (6.207) | 0.109* |